Category Archives: AZBio News

Record Number of Startups Currently Enrolled in the University of Arizona Center for Innovation

Posted on by

Rapid growth seen from entrepreneurs who want to make a significant difference in the local and global communities through innovation. 

TUCSON, Ariz. (January 15, 2021) — The University of Arizona Center for Innovation (UACI) is pleased to announce that more than 40 startups, a record number, are enrolled in the incubation program. Passionate entrepreneurs from across the nation have flocked to UACI. Each one of the 40+ tech and science-based startups are developing solutions for real-world problems and have a strong desire to make a significant difference in the local and global communities through innovation.  

Continue reading→

C-Path Announces SHIP-MD 2021 Virtual Workshop

Posted on by

Multi-stakeholder event will focus on national innovation ecosystem for pediatric medical device development

TUCSON, Ariz., January 14, 2021 — The Critical Path Institute (C-Path) in collaboration with the U.S. Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH), AdvaMed, the American Academy of Pediatrics (AAP) and multiple pediatric health system leaders, is proud to announce the System of Hospitals for Innovation in Pediatrics – Medical Devices (SHIP-MD) Virtual Workshop to be held on February 9-11, 2021. The workshop will focus on the acceleration of medical device development for the unique needs of children.

Continue reading→

FDA Releases Final Rule on the Safer Technologies Program for Medical Devices (STeP)

Posted on by

The FDA is introducing a new, voluntary program for certain medical devices and device-led combination products1 that are reasonably expected to significantly improve the safety of currently available treatments or diagnostics that target an underlying disease or condition associated with morbidities and mortalities less serious than those eligible for the Breakthrough Devices Program.

Learn about the  Safer Technologies Program for Medical Devices (STeP) program 

Continue reading→

Johnson & Johnson COVID-19 Vaccine Candidate Interim Phase 1/2a Data Published in New England Journal of Medicine

Posted on by
January 13, 2021 — Interim Phase 1/2a data were published today in the New England Journal of Medicine demonstrating that the Company’s single-dose investigational COVID-19 vaccine candidate (JNJ-78436735) – being developed by the Janssen Pharmaceutical Companies of Johnson & Johnson – provided an immune response that lasted for at least 71 days, the duration of time measured in this study in participants aged 18-55 years. A preview of part of these interim data was posted on medRxiv in September 2020.

Continue reading→

Dr. Laurence Hurley Inducted into the National Academy of Inventors

Posted on by

University of Arizona Health Sciences faculty member Laurence Hurley, PhD, professor emeritus in the College of Pharmacy, has been elected as fellow of the National Academy of Inventors (NAI). The NAI Fellows Program highlights academic inventors who have demonstrated a spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development and the welfare of society.Continue reading→